Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study Conducted Sequentially With 3 Doses Of Ima-638 Administered Sc.
Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study Conducted Sequentially With 3 Doses Of Ima-638 Administered Sc.
Primary purpose is to assess if IMA-638 is safe and improves asthma in subjects with persistent asthma.
Inclusion Criteria:
Exclusion Criteria:
Lake Oswego, Oregon 97035, United States